Peptide Receptor Radionuclide Therapy US Approval Expected Early 2018

Peptide Receptor Radionuclide Therapy US Approval Expected Early 2018

131 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael C. Soulen, MD of the University of Pennsylvania discusses that peptide receptor radionuclide therapy US approval expected early 2018 from ASCO GI 2018.
Up Next Autoplay